C1ORF135-PADI1 Fusion FISH Probe
The C1ORF135-PADI1 Fusion FISH Probe is used to confirm a fusion of the C1ORF135 and PADI1 genes. The fusion of the C1ORF135 and PADI1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| C1ORF135-PADI1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| C1ORF135-PADI1-20-AQAQ | 20 (40 μL) | 200 μL |
|
PADI1 Gene Summary
This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type I enzyme is involved in the late stages of epidermal differentiation, where it deiminates filaggrin and keratin K1, which maintains hydration of the stratum corneum, and hence the cutaneous barrier function. This enzyme may also play a role in hair follicle formation. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
Gene Name: Peptidyl Arginine Deiminase 1
Chromosome: CHR1: 17531620 -17572501
Locus: 1p36.13
Gene Diseases
The C1ORF135 PADI1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|